Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3NIH 1FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Breast Neoplasms 9476Neoplasms 6587Prostatic Neoplasms 4399Colorectal Neoplasms 3977Lung Neoplasms 3642Carcinoma, Non-Small-Cell Lung 3583Pancreatic Neoplasms 2478Carcinoma, Hepatocellular 2411Leukemia, Myeloid, Acute 2265Multiple Myeloma 2120Stomach Neoplasms 2108Neoplasm Metastasis 1911Head and Neck Neoplasms 1869Ovarian Neoplasms 1773Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1729Brain Neoplasms 1699Rectal Neoplasms 1676Melanoma 1654Colonic Neoplasms 1629Leukemia 1500Uterine Cervical Neoplasms 1499Recurrence 1485Esophageal Neoplasms 1311Glioblastoma 1307Lymphoma, Non-Hodgkin 1204Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1109Urinary Bladder Neoplasms 1078Lymphoma, Follicular 1067

Interventions

Multiparametric Magnetic Resonance Imaging 1Exome 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Prostate cancer, familial × Clear all
NCT07416812 2026-02-18

IMPACT

Institute of Oncology Ljubljana

Phase NA Completed
25 enrolled
Genitourinary

Prostate cancer, familial, Prostatic Neoplasms, Genetic Predisposition to Disease

NCT05681416 2023-01-12

ProFam-Risk

Heinrich-Heine University, Duesseldorf

Phase NA Not yet recruiting
300 enrolled
Genitourinary

Prostate cancer, familial, Prostatic Neoplasms, Genetic Predisposition to Disease

NCT02381015 2019-11-22

Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a

Endeavor Health

Phase NA Completed
700 enrolled 13 charts
Genitourinary

Prostate cancer, familial, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡